Latest newsView all news
New IHC antibodies from RevMAb Biosciences
September 03, 2016 - RevMAb Biosciences uses a revolutionary technology that does not require cell fusion and hybridoma generation for the development of monoclonal antibodies. We offer 10% discount on the newest additions to the portfolio!
Don't be fooled. Not all tetramers are created equal!
September 02, 2016 - MBL tetramers have a clear advantage over academic tetramers and other commercial MHC multimer products. Read on, to find out about their important technology.
- RT @MonosanAbs: Visiting ESP/ECP today! Meeting up with our distribution and network partners #IHC #antibodies #pathology https://t.co/BK3w… September 26, 2016 - Sanbio B.V.
- #OvarianCancerDay, Artist in town Dorenda Denissen, designed the amulet for the RubyandRose foundation #amulet https://t.co/WHznPkqytf September 26, 2016 - Sanbio B.V.
- Round up day 2 of a successful #FMR1 demo at the #UCL in Brussels! @Asuragen #fragileX https://t.co/3XUG3jZM1N September 21, 2016 - Sanbio B.V.